MX2010004017A - 5-cianotienopiridinas para el tratamiento de tumores. - Google Patents

5-cianotienopiridinas para el tratamiento de tumores.

Info

Publication number
MX2010004017A
MX2010004017A MX2010004017A MX2010004017A MX2010004017A MX 2010004017 A MX2010004017 A MX 2010004017A MX 2010004017 A MX2010004017 A MX 2010004017A MX 2010004017 A MX2010004017 A MX 2010004017A MX 2010004017 A MX2010004017 A MX 2010004017A
Authority
MX
Mexico
Prior art keywords
sup
thienopyridines
cyano
tumors
treatment
Prior art date
Application number
MX2010004017A
Other languages
English (en)
Inventor
Christiane Amendt
Harmut Greiner
Guenter Hoelzemann
Ulrich Graedler
Djordje Musil
Per Hillertz
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of MX2010004017A publication Critical patent/MX2010004017A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Las nuevas 5-ciano-tienopiridinas de la f?rmula I (ver f?rmula (I)) en donde R1, R2 y R3 tienen los significados indicados en la reivindicaci?n 1, son inhibidores de la quinasa del receptor TGF-beta, y se pueden emplear, por ejemplo, para el tratamiento de tumores.
MX2010004017A 2007-10-16 2008-09-19 5-cianotienopiridinas para el tratamiento de tumores. MX2010004017A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007049451A DE102007049451A1 (de) 2007-10-16 2007-10-16 5-Cyano-thienopyridine
PCT/EP2008/007888 WO2009049743A1 (de) 2007-10-16 2008-09-19 5-cyano-thienopyridine zur behandlung von tumoren

Publications (1)

Publication Number Publication Date
MX2010004017A true MX2010004017A (es) 2010-04-27

Family

ID=40262956

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010004017A MX2010004017A (es) 2007-10-16 2008-09-19 5-cianotienopiridinas para el tratamiento de tumores.

Country Status (16)

Country Link
US (1) US8202882B2 (es)
EP (1) EP2197886B1 (es)
JP (1) JP5480811B2 (es)
KR (1) KR20100076026A (es)
CN (1) CN101827851A (es)
AR (1) AR068872A1 (es)
AU (1) AU2008314245B2 (es)
BR (1) BRPI0818170A2 (es)
CA (1) CA2702551A1 (es)
DE (1) DE102007049451A1 (es)
EA (1) EA201000618A1 (es)
ES (1) ES2401936T3 (es)
IL (1) IL205137A0 (es)
MX (1) MX2010004017A (es)
WO (1) WO2009049743A1 (es)
ZA (1) ZA201003425B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7904970B2 (en) 2009-02-20 2011-03-15 J-Brem, LLC Headwear with features for holding eyeglasses
KR20120124469A (ko) 2010-02-05 2012-11-13 메르크 파텐트 게엠베하 헤트아릴-［1,8］나프티리딘 유도체
AU2011217561B2 (en) 2010-02-22 2016-04-21 Merck Patent Gmbh Hetarylaminonaphthyridines
SG11201405918XA (en) * 2012-03-20 2014-10-30 Seragon Pharmaceuticals Inc Estrogen receptor modulators and uses thereof
US9801863B2 (en) 2012-04-16 2017-10-31 Case Western Reserve University Inhibitors of short-chain dehydrogenase activity for modulating hematopoietic stem cells and hematopoiesis
WO2014111037A1 (zh) * 2013-01-18 2014-07-24 上海昀怡健康管理咨询有限公司 五元并六元杂环化合物、其制备方法、药物组合物和应用
AU2014342811B2 (en) 2013-10-15 2019-01-03 Board Of Regents Of The University Of Texas System Compositions and methods of modulating short-chain dehydrogenase activity
EP3267995A4 (en) 2015-03-08 2019-02-27 Case Western Reserve University INHIBITORS OF SHORT CHAIN DEHYDROGENASE ACTIVITY FOR THE TREATMENT OF FIBROSIS
WO2018102552A1 (en) 2016-11-30 2018-06-07 Case Western Reserve University Combinations of 15-pgdh inhibitors with corcosteroids and/or tnf inhibitors and uses thereof
CA3052466A1 (en) 2017-02-06 2018-08-09 Case Western Reserve University Compositions and methods of modulating short-chain dehydrogenase activity

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747469A (en) 1991-03-06 1998-05-05 Board Of Regents, The University Of Texas System Methods and compositions comprising DNA damaging agents and p53
GB9904387D0 (en) 1999-02-25 1999-04-21 Pharmacia & Upjohn Spa Antitumour synergistic composition
WO2000061186A1 (en) 1999-04-08 2000-10-19 Arch Development Corporation Use of anti-vegf antibody to enhance radiation in cancer therapy
GB0323810D0 (en) 2003-10-10 2003-11-12 Cancer Rec Tech Ltd Pyridothiophene compounds
WO2005058315A1 (en) 2003-12-12 2005-06-30 Ribapharm, Inc. Novel heterocyclic compounds as ikk2 inhibitors with anti-hbv activity
DE102005009440A1 (de) * 2005-03-02 2006-09-07 Merck Patent Gmbh Thienopyridinderivate
DE102005024245A1 (de) 2005-05-27 2006-11-30 Merck Patent Gmbh Thienopyridine

Also Published As

Publication number Publication date
AR068872A1 (es) 2009-12-09
CA2702551A1 (en) 2009-04-23
ZA201003425B (en) 2011-04-28
JP5480811B2 (ja) 2014-04-23
IL205137A0 (en) 2010-11-30
AU2008314245B2 (en) 2013-07-18
BRPI0818170A2 (pt) 2017-05-16
EP2197886A1 (de) 2010-06-23
US20100234369A1 (en) 2010-09-16
KR20100076026A (ko) 2010-07-05
JP2011500610A (ja) 2011-01-06
EP2197886B1 (de) 2012-12-26
DE102007049451A1 (de) 2009-04-23
AU2008314245A1 (en) 2009-04-23
ES2401936T3 (es) 2013-04-25
US8202882B2 (en) 2012-06-19
CN101827851A (zh) 2010-09-08
EA201000618A1 (ru) 2011-04-29
WO2009049743A1 (de) 2009-04-23

Similar Documents

Publication Publication Date Title
MX2010004017A (es) 5-cianotienopiridinas para el tratamiento de tumores.
MX2009013077A (es) Derivados dde benzoxazolona.
MX2010003368A (es) Derivados de imidazol.
MX2009012708A (es) Derivados de piridazinona.
UA100540C2 (en) 2-benzylpyridazinone derivatives as met kinase inhibitors
MX2008002104A (es) Derivados de 1-acildihidropirazol.
MX2009010034A (es) Pirimidodiazepinas sustituidas utiles inhibidores de la plk1.
MY163477A (en) Pyrimidinyl-pyridazinone derivatives
MX2010003366A (es) Derivados de piperidina y piperazina para el tratamiento de tumores.
MX2009013341A (es) Derivados de 6-(pirrolopiridinil)-pirimidinil-2-amina.
IL191832A (en) Pyridiazinone compounds and their use in the preparation of drugs for the treatment of tumors
MX2010007392A (es) Antagonistas de trpa1.
SG178986A1 (en) 4-substituted pyridin-3-yl-carboxamide compounds and methods of use
WO2010000364A8 (de) Pyrrolopyridinyl-pyrimidin-2-yl-amin-derivate
MX2010003365A (es) Derivados de tiazol para el tratamiento de cancer.
MX2009012709A (es) Derivados de arileter-piridazinona.
PH12013502369A1 (en) Diazacarbazoles and methods of use
MX2010007391A (es) Antagonistas de trpa1.
MX2008001538A (es) Aril piridinas y metodos para su uso.
EA201100035A1 (ru) Производные тиазолилпиперидина
WO2009124653A3 (de) Thienopyrimidine
GB0524814D0 (en) Compounds
MX2012006822A (es) 1,7-diazacarbazoles y metodos de uso.
MX2011007165A (es) Derivados de piridazinona.
IL198465A0 (en) Triazabenzo[e]azulene derivatives for the treatment of tumors

Legal Events

Date Code Title Description
FA Abandonment or withdrawal